Wednesday, January 15, 2025
1/15/2025
Abstract The objective of the Purdue Drug Discovery Training Program (PDD-TP) is to provide predoctoral students with a comprehensive and balanced perspective of drug discovery and development, and to develop a multi-disciplinary approach toward the design of novel molecular entities with promising medicinal activity, with subsequent optimization and preclinical evaluation. Trainees will take an integrated curriculum that expands their breadth of knowledge and experimental approach toward the discovery of novel targets for drug development, and will participate in a research embedding project outside their primary laboratory for further experience and training. Trainees will also participate in program-specific activities intended to enhance communication, critical thinking, leadership, management, mentorship, networking, and entrepreneurism. Activities include a journal club, formal presentations of cross-disciplinary research, organization of seminars in drug discovery, unique opportunities to engage experts in the evaluation of drug pipeline candidates, and participation in a mock drug panel review. Every effort will be made to maximize the diversity of training program applicants, and to recruit and retain trainees of diverse backgrounds. PDD-TP trainees will graduate with a comprehensive skill set and exposure to drug discovery and pipeline development, and with experiences that will continue to serve them long after they enter the biomedical workforce.
HHS’ Tracking Accountability in Government Grants System (TAGGS) website provides access to detailed descriptions of grants, loans, aggregated direct payments and other types of financial assistance awarded by the HHS Operating Divisions (OPDIVs) and the Office of the Secretary Staff Divisions (STAFFDIVs).